Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...
Ketamine molecules contain two parts: S-ketamine (esketamine), which is like the left hand, and R-ketamine, which is like the right hand, McClure said. “Standard ketamine is a mixture of the two ...
Hosted on MSN6d
FDA approves J&J's patented psychedelic esketamine for depression without requiring you take other antidepressants with itOn Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name ...
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...
Merrill said there has been debate within the scientific and medical communities about the difference between esketamine versus ketamine, and whether esketamine is as effective as regular ketamine.
Esketamine, the chemical name for Spravato, is a chemical mirror image of anesthetic ketamine, which is also abused as a recreational party drug and goes by the street nickname “Special K”.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback